Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Articles|January 28, 2021
How to Keep Health Care Workers Safe While Administering the COVID-19 Vaccine
Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on how pharmacies and other health care setting can keep their employees and patients safe as they administer the COVID-19 vaccine.
Advertisement
Pharmacy Times® interviewed Rob LaHayne, the CEO of TouchCare, on how pharmacies and other health care setting can keep their employees and patients safe as they administer the coronavirus disease 2019 (COVID-19) vaccine.
For the full conversion, see the video above.
Advertisement
Related to this article
The data help pharmacists predict who will react strongly to mRNA vaccines—giving them a science-backed talking point during respiratory season.
Isatuximab plus Iberdomide maintenance helps MRD-positive myeloma patients turn MRD-negative after transplant, with manageable safety.
Insulin efsitora alfa-gobe (Onswik; Eli Lilly) is designed to deliver steady basal insulin levels over a full 7-day duration.
Vallerie McLaughlin, MD, explains why the ERS update strongly recommends sotatercept for patients with pulmonary arterial hypertension (PAH) who don't reach low-risk status on initial therapy.
Imaging data from the CONTENTed study suggest the type 2 inflammation that drives severe asthma may affect more than the airways.
Renal benefit appeared only in patients with albuminuria in a 75,455-person BMJ analysis, whereas sulfonylureas signaled faster decline without it.
Authors of a pharmacist-directed transitions-of-care study discuss what drives pneumococcal vaccine hesitancy and how pharmacists can build systematic vaccine screening into inpatient workflows.
Advertisement
Advertisement
Trending on Pharmacy Times
1
After 180 Years, Multiple Myeloma Gets a Definition of Cure
2
Severe Asthma's Effects May Extend Beyond the Lungs, Brain Imaging Study Suggests
3
Alcohol and GLP-1 Therapy: Key Counseling Points for Pharmacists
4
Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps
5